TacticScaleWhat Thermo Fisher Scientific Does & How It Makes Money (TMO)
Updated October 2026 · reflects Thermo Fisher Scientific's latest reported financials
Global supplier of lab tools, diagnostics, and drug development services. It earns revenue by selling instruments and the recurring consumables, reagents, software, and services that go with them to pharma, biotech, academic, government, industrial, and clinical customers.
How Thermo Fisher Scientific makes money
It earns revenue by selling instruments and the recurring consumables, reagents, software, and services that go with them to pharma, biotech, academic, government, industrial, and clinical customers. It also earns fees from contract pharma services and clinical research, and distributes lab and safety products through its channel businesses.
What Thermo Fisher Scientific does
Thermo Fisher Scientific, founded in 1956 and headquartered in Waltham, Massachusetts, supplies a very broad range of tools and services to science and healthcare. It has four segments. Life Sciences Solutions provides reagents, instruments, and consumables for biological research, drug and vaccine production, and disease diagnosis. Analytical Instruments sells instruments, software, and services to pharma, academic, government, environmental, industrial, and clinical labs. Specialty Diagnostics covers clinical immunodiagnostic reagents and blood-test systems for allergy, asthma, and autoimmune diseases, as well as microbiology products for pathogen detection, transplant (HLA) testing, and healthcare channel offerings. Laboratory Products and Biopharma Services combines lab product and research/safety distribution with pharma services and clinical research. Together, these segments reach customers from early-stage research through diagnostics and drug development.
Products & services
- Life science research reagents, instruments and consumables
- Analytical instruments, software and services
- Immunodiagnostic blood-test systems for allergy, asthma and autoimmune diseases
- Microbiology culture media and pathogen detection products
- HLA typing and transplant diagnostics
- Pharma services and clinical research (CRO/CDMO)
What is Thermo Fisher Scientific worth?
On an owner-earnings DCF, Thermo Fisher Scientific's most-likely value is about $498 versus a recent price near $658 (24% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$212) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 5.2× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Danaher (DHR) · Waters (WAT) · Bio-Rad Laboratories (BIO) · Bio-Techne (TECH) · Agilent Technologies (A)